Biohaven Ltd (BHVN)
40.69
+0.79
(+1.98%)
USD |
NYSE |
May 03, 16:00
40.68
-0.01
(-0.02%)
After-Hours: 20:00
Biohaven Cash from Investing (Quarterly): -3.914M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -3.914M |
| September 30, 2023 | 58.55M |
| June 30, 2023 | 76.25M |
| March 31, 2023 | -1.059M |
| Date | Value |
|---|---|
| December 31, 2022 | -264.02M |
| September 30, 2022 | -4.524M |
| June 30, 2022 | -36.00M |
| March 31, 2022 | -0.246M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-264.02M
Minimum
Dec 2022
76.25M
Maximum
Jun 2023
-21.87M
Average
-2.486M
Median
Cash from Investing (Quarterly) Benchmarks
| Amgen Inc | -217.00M |
| Eli Lilly and Co | -1.178B |
| Regeneron Pharmaceuticals Inc | -1.687B |
| Viking Therapeutics Inc | -459.79M |
| Alnylam Pharmaceuticals Inc | -67.62M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -114.88M |
| Cash from Financing (Quarterly) | 245.24M |
| Free Cash Flow | -334.77M |
| Free Cash Flow Per Share (Quarterly) | -1.441 |
| Free Cash Flow Yield | -11.56% |